"Social media and mobile reporting: Impact on PV operations"

Email address:

First name:

Last name:

Job title:

Company name:

Country:

I work for

Please specify your industry *

please check before submitting

Mobile number:

What is your role?

Unfortunately the document is not available at this current time, however if you leave your details we'll get it to you as soon as we can.

Please fill in all the information requested. It is very important you enter this information correctly so we can contact you with the document.

Privacy statement »

Manage your email preferences »

Remember my details Information

Remember my details

We place a 'cookie' on your computer so next time you visit us you don't need to fill in all these details

close »

Last year at the World Drug Safety Congress Europe, Dr David Lewis, Global head of pharmacovigilance, Novartis, gave the presentation "social media and mobile reporting: Impact on PV operations."

Dr David Lewis discusses in his presentation:

Social Media landscape and pharmaceutical medicines
Regulations guidelines for PV of digital media
Mobile reporting applications for pharmacovigilance
Social media as a source of ICSR s & potential signals - case studies focusing on company- sponsored activities
WEB RADR IMI project- assessment of pharmacovigilance using social media Mobile reporting of suspected adverse reactions

"Social media and mobile reporting: Impact on PV operations"

information we require

please check before submitting